# The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction

> **NCT00611169** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** tirofiban

## Key facts

- **NCT ID:** NCT00611169
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611169, "The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00611169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*